ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2026
Upfront radiotherapy as part of the multimodal treatment of intravascular papillary endothelial hyperplasia (Masson's tumor) of the neurocranium-a case report and review of the literature.
Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIntravascular papillary endothelial hyperplasia (IPEH, "Masson's tumor") is a rare benign tumor of vascular origin. It may occur at various anatomical sites and is often preceded by local stress conditions such as trauma or even stereotactic radiotherapy. The treatment normally requires surgical resection, as tumors are able to grow rapidly and cause symptoms that can limit activities of daily life.
methodsWe present the case of a 77-year-old woman developing IPEH in the left supraorbital skull after facial trauma, leading to rapid mutilating tumor growth and causing loss of functionality of the left eye. Since a surgical approach was initially not possible due to the bleeding risk, local radiotherapy was applied. Because radiotherapy can also be a cause of IPEH, we discuss its use as part of a multimodal treatment strategy based on the available literature.
resultsEvidence regarding the optimal treatment of IPEH is limited. Several case reports link its appearance to prior stereotactic radiotherapy. In our case, the application of normofractionated radiotherapy resulted in a stop of tumor growth. After additional necrosectomy, the patient regained functionality of her left eye and was less limited in everyday activities.
conclusionWhile stereotactic radiotherapy has been linked to the development of IPEH in selected reports, normofractionated radiotherapy achieved meaningful local control in this case and facilitated further surgical treatment.
Indexed as
Identifiers
42776195What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.